Hepatitis Monthly

Published by: Kowsar

Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran

Hasan Afzali 1 , Mansooreh Momen-Heravi 2 , * and Asefeh Farokhzad 3
Authors Information
1 Associate Professor, Department of Infectious Disease, School of Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
2 Associate Professor, Department of Infectious Disease, Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
3 Infectious Disease Specialist, Department of Infectious Disease, School of Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
Article information
  • Hepatitis Monthly: July 01, 2016, 16 (7); e30459
  • Published Online: June 5, 2016
  • Article Type: Research Article
  • Received: June 6, 2015
  • Revised: April 12, 2016
  • Accepted: May 28, 2016
  • DOI: 10.5812/hepatmon.30459

To Cite: Afzali H, Momen-Heravi M, Farokhzad A. Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran, Hepat Mon. 2016 ; 16(7):e30459. doi: 10.5812/hepatmon.30459.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. AIDS. 2012; 26(10): 1205-13[DOI][PubMed]
  • 2. Olubajo B, Mitchell-Fearon K, Ogunmoroti O. A Comparative Systematic Review of the Optimal CD4 Cell Count Threshold for HIV Treatment Initiation. Interdiscip Perspect Infect Dis. 2014; 2014: 625670[DOI][PubMed]
  • 3. Clausen LN, Lundbo LF, Benfield T. Hepatitis C virus infection in the human immunodeficiency virus infected patient. World J Gastroenterol. 2014; 20(34): 12132-43[DOI][PubMed]
  • 4. Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases. 2014;
  • 5. Pellicano R, Fagoonee S, Repici A, Rizzetto M. Hepatitis C virus and human immunodeficiency virus: a dangerous dealing. Panminerva Med. 2007; 49(2): 79-82[PubMed]
  • 6. Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012; 55 Suppl 1-42[DOI][PubMed]
  • 7. Grzeszczuk A, Wandalowicz AD, Jaroszewicz J, Flisiak R. Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland. Hepat Mon. 2015; 15(7)[DOI][PubMed]
  • 8. Andersson K, Chung RT. Hepatitis C Virus in the HIV-infected patient. Clin Liver Dis. 2006; 10(2): 303-20[DOI][PubMed]
  • 9. Tan YJ, Lim SG, Hong W. Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection. Curr HIV Res. 2006; 4(1): 21-30[PubMed]
  • 10. Bova C, Ogawa LF, Sullivan-Bolyai S. Hepatitis C treatment experiences and decision making among patients living with HIV infection. J Assoc Nurses AIDS Care. 2010; 21(1): 63-74[DOI][PubMed]
  • 11. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010; 14(1)-33[DOI][PubMed]
  • 12. Davoodian P, Dadvand H, Mahoori K, Amoozandeh A, Salavati A. Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002. Braz J Infect Dis. 2009; 13(5): 356-8[DOI][PubMed]
  • 13. Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, et al. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy. 2010; 21(6): 493-500[DOI][PubMed]
  • 14. Cachay ER, Peterson MR, Goicoechea M, Mathews WC. Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study. Br J Med Med Res. 2011; 1(4): 346-55[PubMed]
  • 15. Cotte L, Benet T, Billioud C, Miailhes P, Scoazec JY, Ferry T, et al. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. J Hepatol. 2011; 54(3): 489-96[DOI][PubMed]
  • 16. Bissonnette J, Genereux A, Cote J, Nguyen B, Perreault P, Bouchard L, et al. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension. J Gastroenterol Hepatol. 2012; 27(8): 1336-40[DOI][PubMed]
  • 17. Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis. 2012; 32(2): 103-13[DOI][PubMed]
  • 18. Demberg T, Robert-Guroff M. Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol. 2012; 3: 250[DOI][PubMed]
  • 19. Alavian SM, Adibi P, Zali M. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005; 8(2): 84-90
  • 20. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007; 37(2): 101-3[DOI][PubMed]
  • 21. Khaja MN, Madhavi C, Thippavazzula R, Nafeesa F, Habib AM, Habibullah CM, et al. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol. 2006; 6(3): 198-204[DOI][PubMed]
  • 22. Assarehzadegan M, Shakerinejad G, Norouzirad R, Amini A. Distribution of hepatitis C virus genotypes among patients with hepatitis C infection in Khuzestan province. Sci Med J .
  • 23. Badie BM, SeyedAlinaghi SA, Chaman R, Hosseini M, Hasibi M, Moharrami B, et al. Frequency and correlates of co-infection hepatitis c and hepatitis b with hiv.
  • 24. Kerubo G, Khamadi S, Okoth V, Madise N, Ezeh A, Abdalla Z, et al. Hepatitis B, hepatitis C and HIV-1 coinfection in two informal urban settlements in Nairobi, Kenya. PloS one. 2015; 10(6)
  • 25. Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC research notes. 2013; 6(1): 363
  • 26. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004; 33(1): 182-8[DOI][PubMed]
  • 27. Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care. 2009; 21(1): 7-16[DOI][PubMed]
  • 28. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007; 356(14): 1445-54[DOI][PubMed]
  • 29. Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P, et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009; 3(5): 369-75[PubMed]
  • 30. UNAIDS report on the global AIDS epidemic 2012;
  • 31. Report on the global AIDS epidemic 2008;
  • 32. Taeri K, Kasaeian N, Nobari RF, Ataei B. The prevalence of hepatitis B, hepatitis C and associated risk factors in intravenous drug addicts (IVDA) with HIV in Isfahan. J Isfahan Med Sch. 2008; 26(90)
  • 33. Vahdat K, Amini A, Motamed N, Eghbali SS, Zandi K, Hajiani G. Determination of Hepatit C genotype and risk factors of transmission in Bushehr province. 2008; 15(1): 51-8
  • 34. Khodabandehloo M, Roshani D. Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis. Hepat mon. 2014; 14(12)
  • 35. Hadinedoushan H, Salmanroghani H, Amirbaigy MK, Akhondi-Meybodi M. Hepatitis C virus genotypes and association with viral load in yazd, central province of Iran. Hepat mon. 2014; 14(3)
  • 36. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004; 74(2): 246-52[DOI][PubMed]
  • 37. Moradi A, Semnani S, Keshtkar A, Khodabakhshi B, Kazeminejad V, Molana A, et al. Distribution of hepatitis C virus genotype among HCV infected patients in Golestan province, Iran. Govaresh. 2010; 15(1): 7-13
  • 38. Ahmadipour MH, Alavian SM, Amini S, Azadmanesh K. Hepatitis c virus genotypes. Hepat Mon. 2005; 5(3): 77-82
  • 39. Mohammadnejad E, Jalaimanesh S, Mahmoodi M. Clinical syndrome in HIV/AIDS resulting in hospitalization based on the CD4 count. J Mazandaran Univ Med Scie. 2010; 19(74): 70-7
  • 40. Korner C, Kramer B, Schulte D, Coenen M, Mauss S, Fatkenheuer G, et al. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients. Clin Sci (Lond). 2009; 116(12): 861-70[DOI][PubMed]
  • 41. Ajayi EA, Ajayi AO, Adegun PT, Ajayi IA, Ojo AA, Raimi HT. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. Pan African Med J. 2011; 9(1)
  • 42. Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. African Health Sci. 2013; 12(3): 312-7
  • 43. Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol. 2003; 98(7): 1588-93[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments